...
首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Pseudolaric Acid B Induces Caspase-Dependent and Caspase-Independent Apoptosis in U87 Glioblastoma Cells
【24h】

Pseudolaric Acid B Induces Caspase-Dependent and Caspase-Independent Apoptosis in U87 Glioblastoma Cells

机译:Pseudolaric Acid B诱导U87胶质母细胞瘤细胞中Caspase依赖性和Caspase依赖性凋亡

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Pseudolaric acid B (PLAB) is one of the major bioactive components ofPseudolarix kaempferi. It has been reported to exhibit inhibitory effect on cell proliferation in several types of cancer cells. However, there is no report elucidating its effect on glioma cells and organ toxicityin vivo. In the present study, we found that PLAB inhibited growth of U87 glioblastoma cells in a dose-dependent manner with IC50~10 μM. Flow cytometry analysis showed that apoptotic cell death mediated by PLAB was accompanied with cell cycle arrest at G2/M phase. Using Western blot, we found that PLAB induced G2/M phase arrest by inhibiting tubulin polymerization in U87 cells. Apoptotic cell death was only partially inhibited by pancaspase inhibitor, z-VAD-fmk, which suggested that PLAB-induced apoptosis in U87 cells is partially caspase-independent. Further mechanistic study demonstrated that PLAB induced caspase-dependent apoptosis via upregulation of p53, increased level of proapoptotic protein Bax, decreased level of antiapoptotic protein Bcl-2, release of cytochrome c from mitochondria, activation of caspase-3 and proteolytic cleavage of poly (ADP-ribose) polymerase (PARP) and caspase-independent apoptosis through apoptosis inducing factor (AIF). Furthermore,in vivotoxicity study demonstrated that PLAB did not induce significant structural and biochemical changes in mouse liver and kidneys at a dose of 25 mg/kg. Therefore, PLAB may become a potential lead compound for future development of antiglioma therapy.
机译:伪laric acid B(PLAB)是Pseudolarix kaempferi的主要生物活性成分之一。据报道在几种类型的癌细胞中表现出对细胞增殖的抑制作用。然而,没有报道阐明其对体内神经胶质瘤细胞和器官毒性的作用。在本研究中,我们发现PLAB抑制U87胶质母细胞瘤细胞的生长具有剂量依赖性,其IC50〜10μM。流式细胞仪分析表明,由PLAB介导的凋亡细胞死亡伴随细胞周期停滞在G2 / M期。使用蛋白质印迹,我们发现PLAB通过抑制U87细胞中的微管蛋白聚合诱导G2 / M期停滞。胰腺蛋白酶抑制剂z-VAD-fmk仅部分抑制凋亡细胞的死亡,这表明PLAB诱导的U87细胞凋亡是部分不依赖胱天蛋白酶的。进一步的机理研究表明,PLAB通过上调p53,增加凋亡蛋白Bax的水平,降低抗凋亡蛋白Bcl-2的水平,从线粒体释放细胞色素c,激活caspase-3以及蛋白水解性裂解来诱导caspase依赖性凋亡。 ADP-核糖)聚合酶(PARP)和不依赖半胱天冬酶的凋亡,通过凋亡诱导因子(AIF)进行。此外,体内毒性研究表明,剂量为25μmg/ kg的PLAB不会在小鼠肝脏和肾脏中引起明显的结构和生化变化。因此,PLAB可能成为抗神经胶质瘤治疗未来发展的潜在先导化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号